Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

NORRISTOWN, PA — MRO Corp. has announced the acquisition of Q-Centrix Corp., a recognized leader in enterprise clinical data management. This strategic move positions MRO to enhance clinical data ...

CareInTelligence identifies trends and generates insights when needed, thereby improving patient outcomes and enhancing care ...

Dr. Anna Maria V. Storniolo, director of biospecimen collection and biobanking core at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and her team are responsible for the ...

Adoption of Datatrak's eClinical solution enables CRO to actively manage all clinical trial data, processes, and documents on a single platform and dashboard with the first true eSource solution that ...

France-based clinical research company Aixial Group is consolidating clinical data from one of its business units into Medidata’s digital platform, according to a Sept. 3 release. The partnership will ...

NEW YORK--(BUSINESS WIRE)--Datavant, the leading health data platform company, today announced the launch of the Datavant Clinical Insights Platform, an integrated offering that empowers health plans ...

Deloitte’s patient engagement platform suite ConvergeHealth on Feb. 18 launched a new digital platform on Amazon Web Services that connects patients and investigators with clinical research trials.

Salt Lake City-based Intermountain Health is partnering with health AI company Layer Health to streamline how it manages clinical data. The multi-year collaboration, announced in a June 17 news ...

Today, clinical research has many manual processes and legacy tools, where the collection, management, and analysis of data for clinical research happens in tools like Excel spreadsheets, SAS, and ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...